Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A van der Velden

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The Journal of Investigative Dermatology. Symposium Proceedings|October 28, 1999
Familial melanoma; CDKN2A and beyondN A Gruis, P A van der Velden, W Bergman, et al.
Bulletin Du Cancer|September 30, 1998
Genetics of familial atypical multiple mole-melanoma (FAMMM) syndrome in The Netherlands: how far have we come?N A Gruis, P A Van der Velden, W Bergman, et al.
British Journal of Haematology|July 1, 1993
Instability of repeats of the von Willebrand factor gene variable number tandem repeat sequence in intron 40J C Eikenboom, P H Reitsma, P A van der Velden, et al.
Melanoma Research|June 1, 1995
CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome familiesN A Gruis, L A Sandkuijl, P A van der Velden, et al.
Thrombosis and Haemostasis|June 1, 1994
Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS)T Koster, F R Rosendaal, P H Reitsma, et al.
Thrombosis and Haemostasis|May 6, 1991
A frequent thrombomodulin amino acid dimorphism is not associated with thrombophiliaP A van der Velden, T Krommenhoek-Van Es, C F Allaart, et al.
International Journal of Cancer|August 24, 2000
Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden)H F Vasen, N A Gruis, R R Frants, et al.
Genome Research|July 13, 1999
A locus linked to p16 modifies melanoma risk in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome familiesP A van der Velden, L A Sandkuijl, W Bergman, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 1, 1996
Use of the direct RNA amplification technique NASBA to detect factor V Leiden, a point mutation associated with APC resistanceP H Reitsma, P A van der Velden, E Vogels, et al.
American Journal of Human Genetics|August 14, 2001
Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanomaP A van der Velden, L A Sandkuijl, W Bergman, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The Journal of Investigative Dermatology. Symposium Proceedings|October 28, 1999
Familial melanoma; CDKN2A and beyondN A Gruis, P A van der Velden, W Bergman, et al.
Bulletin Du Cancer|September 30, 1998
Genetics of familial atypical multiple mole-melanoma (FAMMM) syndrome in The Netherlands: how far have we come?N A Gruis, P A Van der Velden, W Bergman, et al.
British Journal of Haematology|July 1, 1993
Instability of repeats of the von Willebrand factor gene variable number tandem repeat sequence in intron 40J C Eikenboom, P H Reitsma, P A van der Velden, et al.
Melanoma Research|June 1, 1995
CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome familiesN A Gruis, L A Sandkuijl, P A van der Velden, et al.
Thrombosis and Haemostasis|June 1, 1994
Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS)T Koster, F R Rosendaal, P H Reitsma, et al.
Thrombosis and Haemostasis|May 6, 1991
A frequent thrombomodulin amino acid dimorphism is not associated with thrombophiliaP A van der Velden, T Krommenhoek-Van Es, C F Allaart, et al.
International Journal of Cancer|August 24, 2000
Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden)H F Vasen, N A Gruis, R R Frants, et al.
Genome Research|July 13, 1999
A locus linked to p16 modifies melanoma risk in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome familiesP A van der Velden, L A Sandkuijl, W Bergman, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 1, 1996
Use of the direct RNA amplification technique NASBA to detect factor V Leiden, a point mutation associated with APC resistanceP H Reitsma, P A van der Velden, E Vogels, et al.
American Journal of Human Genetics|August 14, 2001
Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanomaP A van der Velden, L A Sandkuijl, W Bergman, et al.
Pageof 2